{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:10Z","timestamp":1793400070864,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["ISCIII-FEDER PI20\/01063"],"award-info":[{"award-number":["ISCIII-FEDER PI20\/01063"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-138461OB-I00"],"award-info":[{"award-number":["PID2022-138461OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.037","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:20:22Z","timestamp":1746213622000},"page":"600-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Leyre","family":"Ayerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Abellanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Vidaurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Basurco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Tavira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Clavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mengual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Collantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pe\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Ruiz","family":"de Martin-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Grether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia J.","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Herv\u00e1s-Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-1538","authenticated-orcid":false,"given":"Maria S.","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2025.04.037_b0005","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.bbi.2025.04.037_b0010","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1046\/j.1432-1327.2000.01550.x","article-title":"Comparative biology of the endocannabinoid system possible role in the immune response","volume":"267","author":"Salzet","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbi.2025.04.037_b0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2018.08.016","article-title":"Cannabinoid pharmacology\/therapeutics in chronic degenerative disorders affecting the central nervous system","volume":"157","author":"Aymerich","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"6441","key":"10.1016\/j.bbi.2025.04.037_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.037_b0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"Synapse"},{"issue":"12","key":"10.1016\/j.bbi.2025.04.037_b0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/syn.20569","article-title":"Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"issue":"35","key":"10.1016\/j.bbi.2025.04.037_b0040","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.037_b0045","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4814-06.2007","article-title":"Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis","volume":"27","author":"Benito","year":"2007","journal-title":"J. Neurosci."},{"issue":"64","key":"10.1016\/j.bbi.2025.04.037_b0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson\u2019s disease","volume":"4","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2025.04.037_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2025.04.037_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175882","article-title":"Parkinson\u2019s disease-associated genetic variation is linked to quantitative expression of inflammatory genes","author":"Pierce","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbi.2025.04.037_b0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.bbi.2025.04.037_b0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2025.04.037_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7795","article-title":"Functional variants in the LRRK2 gene confer shared effects on risk for Crohn\u2019s disease and Parkinson\u2019s disease","author":"Hui","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2025.04.037_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3225","article-title":"Central and peripheral innate and adaptive immunity in Parkinson\u2019s disease","author":"Harms","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.037_b0085","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbi.2025.04.037_b0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.037_b0095","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"Fc\u03b5RII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-\u03b1 in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","article-title":"\u03b1-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration","volume":"5","author":"Harms","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-024-03091-x","article-title":"Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity","volume":"21","author":"Ayerra","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0110","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bbi.2025.04.037_b0115","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain [internet]."},{"key":"10.1016\/j.bbi.2025.04.037_b0120","doi-asserted-by":"crossref","unstructured":"Grozdanov, V., Bliederhaeuser, C., Ruf, W.P., Roth, V., Fundel-Clemens, K., Zondler, L., et al., 2014. Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol. 2014;128(5):651\u201363.","DOI":"10.1007\/s00401-014-1345-4"},{"issue":"3","key":"10.1016\/j.bbi.2025.04.037_b0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.25300","article-title":"Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson\u2019s disease","volume":"28","author":"Funk","year":"2013","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0130","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1038\/s41598-018-28986-7","article-title":"A monocyte gene expression signature in the early clinical course of Parkinson\u2019s disease","volume":"8","author":"Schlachetzki","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-023-00626-6","article-title":"Immunological shifts during early-stage Parkinson\u2019s disease identified with DNA methylation data on longitudinally collected blood samples","volume":"10","author":"Pike","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41531-022-00438-0","article-title":"Impaired migratory phenotype of CD4+ T cells in Parkinson\u2019s disease","volume":"8","author":"Mamula","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.bbi.2025.04.037_b0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbi.2016.06.010","article-title":"Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson\u2019s disease","volume":"57","author":"Celorrio","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.037_b0150","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2025.04.037_b0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","article-title":"GPR55: a therapeutic target for Parkinson\u2019s disease?","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.bbi.2025.04.037_b0160","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"issue":"7","key":"10.1016\/j.bbi.2025.04.037_b0165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler\u2019s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.bbi.2025.04.037_b0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"6057","key":"10.1016\/j.bbi.2025.04.037_b0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"1979","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.037_b0180","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s12035-015-9213-3","article-title":"Neuroprotective effect of JZL184 in MPP(+)-treated SH-SY5Y cells through CB2 receptors","volume":"53","author":"Aymerich","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.037_b0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","article-title":"Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"issue":"844","key":"10.1016\/j.bbi.2025.04.037_b0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopaminergic neurotoxicity","volume":"30","author":"Miller","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-018-1174-9","article-title":"Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer\u2019s disease","volume":"15","author":"L\u00f3pez","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.bbi.2025.04.037_b0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"16","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.037_b0205","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.037_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cmdc.201500218","article-title":"Novel triazolopyrimidine-derived cannabinoid receptor 2 agonists as potential treatment for inflammatory kidney diseases","volume":"11","author":"Nettekoven","year":"2016","journal-title":"ChemMedChem"},{"issue":"Pt 3","key":"10.1016\/j.bbi.2025.04.037_b0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.037_b0220","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smajic","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2025.04.037_b0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB 2 receptor as a pharmacological target against inflammation in Parkinson\u2019s disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.037_b0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.24089","article-title":"Cannabinoid receptor 2 is necessary to induce toll-like receptor-mediated microglial activation","volume":"70","author":"Reusch","year":"2022","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.bbi.2025.04.037_b0240","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"3","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2025.04.037_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183338","article-title":"Selective cannabinoid 2 receptor agonists as potential therapeutic drugs for the treatment of endotoxin-induced uveitis","author":"Porter","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bbi.2025.04.037_b0250","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"23","key":"10.1016\/j.bbi.2025.04.037_b0255","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.037_b0260","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/glia.24295","article-title":"Microglia and astrocyte activation is region-dependent in the \u03b1-synuclein mouse model of Parkinson\u2019s disease","volume":"71","author":"Basurco","year":"2023","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.bbi.2025.04.037_b0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2006.11.008","article-title":"Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis","volume":"7","author":"Coopman","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2025.04.037_b0270","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12768","article-title":"Potent T cell\u2010mediated anti\u2010inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis","author":"Tiberi","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.037_b0275","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/STROKEAHA.111.631044","article-title":"Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection","volume":"43","author":"Zarruk","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.bbi.2025.04.037_b0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175205","article-title":"Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease","author":"Moe","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.037_b0290","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2025.04.037_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081198","article-title":"CB2 receptors and neuron-glia interactions modulate neurotoxicity generated by MAGL inhibition","author":"Rojo-Bustamante","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12974-019-1628-8","article-title":"Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions","volume":"16","author":"Abellanas","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.037_b0305","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1038\/s41598-023-37702-z","article-title":"Pharmacological blockade of cannabinoid receptor 2 signaling does not affect LPS\/IFN-\u03b3-induced microglial activation","volume":"13","author":"Olabiyi","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.037_b0310","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2015.06.075","article-title":"Metabolic interplay between astrocytes and neurons regulates endocannabinoid action","volume":"12","author":"Viader","year":"2015","journal-title":"Cell Rep."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2025.04.037_b0315","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.bbi.2025.04.037_b0320","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1073\/pnas.0510418103","article-title":"Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection","volume":"103","author":"Witting","year":"2006","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bbi.2025.04.037_b0325","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-tumor necrosis factor therapy and incidence of parkinson disease among patients with inflammatory bowel disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:40:55Z","timestamp":1763444455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":65,"alternative-id":["S0889159125001746"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.037","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}